Thomas Sabia
Corporate Officer/Principal at QUINCE THERAPEUTICS, INC.
Profile
Thomas Sabia is currently the Chief Commercial Officer at EryDel SpA and Quince Therapeutics, Inc. He has an undergraduate degree and an MBA from Salisbury State University.
Thomas Sabia active positions
| Companies | Position | Start |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Corporate Officer/Principal | 2023-09-30 |
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Corporate Officer/Principal | 2022-02-21 |
Training of Thomas Sabia
| Salisbury State University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
- Stock Market
- Insiders
- Thomas Sabia
